4-(Methylsulfonyl)aniline → 6-[(cyclopropylmethyl)(propyl)amino]-N-[4-(methylsulfonyl)phenyl]pyrimidine-4-carboxamide
반응식
[CH:1]1([CH2:4][N:5]([CH2:15][CH2:16][CH3:17])[C:6]2[N:11]=[CH:10][N:9]=[C:8]([C:12]([OH:14])=O)[CH:7]=2)[CH2:3][CH2:2]1.[CH3:18][S:19]([C:22]1[CH:28]=[CH:27][C:25]([NH2:26])=[CH:24][CH:23]=1)(=[O:21])=[O:20]>>[CH:1]1([CH2:4][N:5]([CH2:15][CH2:16][CH3:17])[C:6]2[N:11]=[CH:10][N:9]=[C:8]([C:12]([NH:26][C:25]3[CH:24]=[CH:23][C:22]([S:19]([CH3:18])(=[O:21])=[O:20])=[CH:28][CH:27]=3)=[O:14])[CH:7]=2)[CH2:2][CH2:3]1참가 물질
3
실험 절차
Following the general method as outlined in Example 1, starting from 6-[cyclopropylmethyl)(propyl)amino]pyrimidine-4-carboxylic acid (Intermediate 21) and 4-(methylsulfonyl)aniline (Enamine), the title compound was obtained as a white solid after purification by column chromatography (silica) eluting with cyclohexane containing increasing amounts of EtOAc.
출처 및 근거
- ORD 기록
- ord-e9054bba14ef4d1bb94c762f0154659d
- 출처 데이터셋
- uspto-grants-2015_10